OTHER NEWS - Aug. 14, 1991
ICN Seeks OK for New Use of Antiviral Drug: ICN Pharmaceuticals Inc. of Costa Mesa has applied to the Food and Drug Administration for permission to use the drug Virazole to combat the Hantaan virus, which can cause kidney failure in humans. The rodent-borne disease is uncommon in the United States, but affects about 350,000 people each year, mostly in poorer countries, said Jack Sholl, an ICN spokesman. It is fatal in about 18% to 35% of the cases. The application was made through ICN’s Viratek subsidiary.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.